HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beate Rinner Selected Research

lactoferricin B

1/2020Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.
1/2019Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
9/2017In vitro and in vivo cytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanoma.
11/2015Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
10/2014Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beate Rinner Research Topics

Disease

41Neoplasms (Cancer)
04/2024 - 03/2004
16Melanoma (Melanoma, Malignant)
11/2022 - 05/2012
12Chordoma
12/2021 - 02/2012
9Neoplasm Metastasis (Metastasis)
11/2022 - 11/2005
6Sarcoma (Soft Tissue Sarcoma)
12/2021 - 01/2012
5Breast Neoplasms (Breast Cancer)
04/2024 - 05/2015
4Carcinogenesis
10/2023 - 02/2012
4Liposarcoma
06/2020 - 11/2012
4Thyroid Neoplasms (Thyroid Cancer)
04/2013 - 03/2004
3Triple Negative Breast Neoplasms
12/2023 - 01/2019
3Glioblastoma (Glioblastoma Multiforme)
08/2021 - 11/2015
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2021
2Chondrosarcoma
06/2021 - 01/2016
2Inflammation (Inflammations)
01/2020 - 01/2019
2Necrosis
10/2018 - 11/2015
2Rhabdomyosarcoma
11/2015 - 04/2015
2Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2013 - 11/2009
1Mesothelioma
01/2023
1Residual Neoplasm
05/2021
1Chromosome Aberrations (Chromosome Abnormalities)
01/2021
1Wounds and Injuries (Trauma)
01/2020

Drug/Important Bio-Agent (IBA)

8Peptides (Polypeptides)IBA
11/2022 - 10/2014
7PhosphatidylserinesIBA
08/2021 - 11/2011
6Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2013
6shikoninIBA
05/2022 - 05/2012
5LipidsIBA
08/2021 - 01/2014
5lactoferricin BIBA
01/2020 - 10/2014
4Antineoplastic Agents (Antineoplastics)IBA
04/2024 - 02/2012
4MicroRNAs (MicroRNA)IBA
12/2023 - 11/2018
4Death Domain ReceptorsIBA
05/2022 - 01/2016
3SurvivinIBA
06/2021 - 04/2015
3LigandsIBA
04/2021 - 07/2013
3Antimicrobial Cationic PeptidesIBA
01/2019 - 10/2014
3Caspase 3 (Caspase-3)IBA
11/2015 - 12/2013
3Calcitonin (Calcitonin, Eel)FDA LinkGeneric
11/2009 - 03/2004
2CholesterolIBA
12/2023 - 01/2019
2CytokinesIBA
12/2023 - 06/2010
2Histone Deacetylase InhibitorsIBA
12/2021 - 12/2013
2PanobinostatIBA
12/2021 - 12/2013
2Bortezomib (Velcade)FDA Link
06/2021 - 01/2016
2EnzymesIBA
04/2021 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2019
2periplocinIBA
06/2020 - 12/2018
2Phosphatidylcholines (Phosphatidylcholine)IBA
01/2019 - 09/2017
2Membrane LipidsIBA
01/2019 - 10/2014
2Silybin (Lagosa)IBA
11/2018 - 10/2018
2DNA (Deoxyribonucleic Acid)IBA
03/2017 - 11/2015
2Brachyury protein (Brachyury)IBA
01/2017 - 02/2012
2CaspasesIBA
01/2016 - 04/2015
2neurabinIBA
05/2015 - 09/2014
2Biomarkers (Surrogate Marker)IBA
02/2015 - 01/2013
2Tryptophan (L-Tryptophan)FDA Link
02/2015 - 10/2014
2Matrix Metalloproteinases (MMPs)IBA
07/2013 - 01/2013
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
11/2012 - 01/2012
2NaphthoquinonesIBA
05/2012 - 05/2010
2Plant ExtractsIBA
11/2009 - 03/2004
1Paclitaxel (Taxol)FDA LinkGeneric
04/2024
1Carrier Proteins (Binding Protein)IBA
12/2023
1capivasertibIBA
10/2023
1CD40 Ligand (CD40L)IBA
01/2023
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2023
1Monoclonal AntibodiesIBA
01/2023
1RNA-Binding Proteins (RNA-Binding Protein)IBA
07/2022
1A-factor (Streptomyces)IBA
07/2022
1Messenger RNA (mRNA)IBA
07/2022
1Protein Isoforms (Isoforms)IBA
07/2022
1Long Noncoding RNAIBA
07/2022
1VemurafenibIBA
05/2022
1cobimetinibIBA
05/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2022
1ErbB Receptors (EGF Receptor)IBA
12/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2021
1CrizotinibIBA
12/2021
1AfatinibIBA
12/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2021
1Drug CombinationsIBA
12/2021
1Topoisomerase II InhibitorsIBA
12/2021
1Amino AcidsFDA Link
08/2021
1BuffersIBA
08/2021
1PolymersIBA
06/2021
1Histones (Histone)IBA
06/2021
1Serine (L-Serine)FDA Link
06/2021
1Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2021
1X-Linked Inhibitor of Apoptosis ProteinIBA
06/2021
1GemcitabineFDA Link
05/2021
1Immune Checkpoint InhibitorsIBA
04/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1CollagenIBA
01/2020
1MolybdenumIBA
01/2020
1AlloysIBA
01/2020
1CobaltIBA
01/2020
1matridermIBA
01/2020
1ElastinIBA
01/2020
1matrigelIBA
01/2020

Therapy/Procedure

19Therapeutics
04/2024 - 11/2009
14Drug Therapy (Chemotherapy)
12/2021 - 03/2004
2Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2015 - 03/2004
2Radiotherapy
04/2013 - 11/2009
1Investigational Therapies (Experimental Therapy)
11/2019